Pennsylvania Adolescent Smoking Study (PASStudy)

NCT00381329 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 330

Last updated 2009-01-30

No results posted yet for this study

Summary

The Pennsylvania Adolescent Smoking Study (PASStudy) will evaluate the effectiveness of Motivational Interviewing (MI) compared to Structured Brief Advice (SBA) to reduce cigarette smoking among adolescents who smoke. MI is a brief 5 session client-centered psychotherapeutic style intended to increase "the probability that a person will enter into, continue and adhere to a specific change strategy." This will be compared with SBA, which implements Best Practice Guidelines (i.e., 5 A's and 5 R's) and assists participants in accessing the best available resources for smoking cessation.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

Motivational Interviewing (MI)

MI is an empirically supported, client-centered, directive method for matching counseling to an individual's readiness to change.

BEHAVIORAL

Structured Brief Advice (SBA)

SBA includes the administration of scripted, brief cessation counseling that follows standard health care smoking cessation guidelines.

Sponsors & Collaborators

  • Children's Hospital of Philadelphia

    collaborator OTHER
  • University of Pittsburgh

    collaborator OTHER
  • Lehigh Valley Hospital

    collaborator OTHER
  • Pennsylvania Department of Health

    lead OTHER_GOV

Principal Investigators

  • Janet Audrain-McGovern, Ph.D · University of Pennsylvania

  • Deborah Moss, MD, MPH · University of Pittsburgh

  • Sarah Stevens, MD, MPH · Lehigh Valley Hospital

  • Jon Pletcher, MD · University of Pittsburgh

  • Pamela Murray, MD, MHP · University of Pittsburgh

  • Sara B Kinsman, MD, PhD · The Children's Hospital of Philadelphia/University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
14 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00381329 on ClinicalTrials.gov